As you know, particularly due to its past, GNBT is speculative. And it is small cap and in the bio industry. Banks don't line up to lend to companies like this. Everyone knows that.
You should refrain from presuming what folks know and don't know. Not that it matters, but I am a permanently certified treasury pro. I eat, sleep and breathe this stuff. I've borrowed money from just about every bank in existence, on behalf of one company or another. I've worked for a Fortune 500 healthcare company, and I have a particular interest in the small caps. I think I'm certainty as qualified as many, perhaps more than some, to judge the financing, based upon the public information the company provides, knowing fully well we don't see all the negotiations or details.
